John MacDougall

John MacDougall is a seasoned expert in preclinical pharmacology and oncology with over 18 years of experience in the biopharmaceutical industry. Currently serving as Senior Director of Preclinical Pharmacology at BioNTech SE since September 2023, John has held significant leadership roles including Executive Director of Biology and Pharmacology at Totus Medicines and Head of Research and Development at Aviceda Therapeutics. John's prior positions encompass influential roles at BioXcel Therapeutics, Crown Bioscience, Catenion, Aura Biosciences, ImmuneXcite, Infinity Pharmaceuticals, and Serono. Academic credentials include a Ph.D. in Medical Biophysics from the University of Toronto and postdoctoral training at Vanderbilt University, with a focus on cancer biology and pharmacology.